Who Owns Kiora Pharmaceuticals Stock?
NASDAQ: KPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:42 PM ET
Ownership breakdown
- Held by institutions
- 36.35%
- Held by insiders
- 8.91%
- Institutional holders
- 26
- Institutions 36.3%
- Insiders 8.9%
- Public and other 54.7%
Who owns Kiora Pharmaceuticals stock?
Institutional investors own about 36.3% of Kiora Pharmaceuticals's shares, spread across 26 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.91% of KPRX.
The largest institutional holders are Perceptive Advisors Llc (9.91%), Adar1 Capital Management, LLC (3.80%) and Citadel Advisors Llc (2.62%). Together, the top 10 institutions control 23.5% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their KPRX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KPRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Perceptive Advisors Llc | 438.47K | 9.91% | +100.0% |
| Adar1 Capital Management, LLC | 167.94K | 3.80% | 0.0% |
| Citadel Advisors Llc | 116.01K | 2.62% | +134.2% |
| Two Sigma Investments, LP | 88.79K | 2.01% | +100.0% |
| Millennium Management Llc | 74.20K | 1.68% | +100.0% |
| HRT Financial LP | 58.61K | 1.32% | +100.0% |
| Renaissance Technologies, LLC | 29.82K | 0.67% | +100.0% |
| Geode Capital Management, LLC | 26.72K | 0.60% | -44.2% |
| Vanguard Capital Management LLC | 19.86K | 0.45% | 0.0% |
| Scientech Research LLC | 18.75K | 0.42% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KPRX
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 20.91K | 0.47% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 19.86K | 0.45% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Vector Equity Portfolio | 3.92K | 0.09% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 3.51K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 3.45K | 0.08% |
| Bridgeway Funds, Inc.-Omni Small-Cap Value Fund | 2.00K | 0.05% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Sustainability Core 1 PORT. | 1.90K | 0.04% |
| Dimensional ETF Trust-Dimensional US Core Equity 1 ETF | 1.57K | 0.04% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Social Core Eqy. 2 PORT. | 1.24K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 747 | 0.02% |
Frequently asked questions
Who is the largest shareholder of Kiora Pharmaceuticals?
Perceptive Advisors Llc is the largest institutional shareholder of KPRX, owning 9.91% of shares outstanding (438.47K shares) as of its latest 13F filing.
What percentage of Kiora Pharmaceuticals is owned by institutions?
Institutions own about 36.3% of KPRX shares and 39.9% of the public float.
How much of Kiora Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 8.91% of KPRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.